<code id='C532B3510E'></code><style id='C532B3510E'></style>
    • <acronym id='C532B3510E'></acronym>
      <center id='C532B3510E'><center id='C532B3510E'><tfoot id='C532B3510E'></tfoot></center><abbr id='C532B3510E'><dir id='C532B3510E'><tfoot id='C532B3510E'></tfoot><noframes id='C532B3510E'>

    • <optgroup id='C532B3510E'><strike id='C532B3510E'><sup id='C532B3510E'></sup></strike><code id='C532B3510E'></code></optgroup>
        1. <b id='C532B3510E'><label id='C532B3510E'><select id='C532B3510E'><dt id='C532B3510E'><span id='C532B3510E'></span></dt></select></label></b><u id='C532B3510E'></u>
          <i id='C532B3510E'><strike id='C532B3510E'><tt id='C532B3510E'><pre id='C532B3510E'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:74861
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          FDA panel issues narrow recommendation for Covid vaccine booster doses
          FDA panel issues narrow recommendation for Covid vaccine booster doses

          ROBYNBECK/AFPviaGettyImagesForanarchivedversionoflivecoverageofthehearingoftheFDA’sadvisorypanel,cli

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          FDA seeking to stop procedures at two unregulated stem cell clinics

          StemcellsSpencerPlatt/GettyImagesFederalofficialsmovedonWednesdaytostoptwoclinicsfromcontinuingtooff